Rapid Influenza Diagnostic Tests (RIDT) Market Forecast to 2028 - COVID-19 Impact and Global Analysis By : Product (RIDT for Influenza A, RIDT for Influenza B); Patient (Pediatric, Adult); End User (Hospitals, Diagnostics Centers, Research Laboratories)
Report Code: TIPRE00017827
| No. of Pages: 150
| Category: Medical Device
| Status: Upcoming
Rapid influenza diagnostic tests (RIDTs) are immunoassays that are used to detect the presence of Influenza A and B antigens in the given sample. Rapid influenza diagnostic tests (RIDTs) give quick results in about 15 mins and are easy to perform. Some rapid influenza diagnostic tests use an analyzer device give the test result. These offer higher sensitivities to detect influenza virus antigens than rapid influenza diagnostic tests without analyzer devices.
The rapid influenza diagnostic tests (RIDTs) market is driving due to the growing prevalence of influenza, increase in research funding for influenza diagnostics and treatment, and rising demand for rapid influenza diagnostic tests. Moreover, growing diagnostic industry in developed as well as developing countries is likely to create growth opportunities in the market.
The "Rapid influenza Diagnostic Tests (RIDTs) Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of rapid influenza diagnostic tests (RIDTs) market with detailed market segmentation by product, patient and end user. The rapid influenza diagnostic tests (RIDTs) market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in Rapid influenza diagnostic tests (RIDTs) market and offers key trends and opportunities in the market.
The rapid influenza diagnostic tests (RIDTs) market is segmented on the basis of product, patient and end user. Based on product, the market is segmented as RIDT for Influenza A and RIDT for Influenza B. The patient segment is classified into pediatric and adult. The end user segment is divided into hospitals, diagnostics centers, research laboratories.
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the rapid influenza diagnostic tests (RIDTs) Market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The rapid influenza diagnostic tests (RIDTs) market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting rapid influenza diagnostic tests (RIDTs) market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the rapid influenza diagnostic tests (RIDTs) market in these regions.
Get more information on this report :
The report covers key developments in the rapid influenza diagnostic tests (RIDTs) market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from rapid influenza diagnostic tests (RIDTs) market are anticipated to have lucrative growth opportunities in the future with the rising demand for rapid influenza diagnostic tests (RIDTs) in the global market. Below mentioned is the list of few companies engaged in the rapid influenza diagnostic tests (RIDTs) market.
The report also includes the profiles of key players in rapid influenza diagnostic tests (RIDTs) market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
Becton Dickinson and Company
Meridian Bioscience Inc.
Princeton BioMeditech Corporation
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.
Get more information on this report :
1. DiaSorin S.p.A
2. Becton Dickinson and Company
3. SA Scientific
5. Meridian Bioscience Inc.
7. Analytik Jena
9. Quidel Corporation
10. Princeton BioMeditech Corporation